Following approval, Medtronic began a Customer Training Phase in March to test the device's real-world use. Those that used the MiniMed 670G remained in a healthy blood glucose range 74% of the time.

Medtronic has landed on a new brand for the planned spinout of its diabetes division, and it didn’t have to look very far. The new company will share a name with its flagship insulin pump, MiniMed.

Medtronic's (NYSE:MDT) stand-alone diabetes company, first announced in May, will be known as MiniMed. MiniMed was the original name of the diabetes company Medtronic acquired in 2001. Medtronic ...

GALWAY, Ireland, June 12, 2025 /CNW/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced MiniMed as the name for the planned New Diabetes Company following the ...

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced MiniMed as the name for the planned New Diabetes Company following the intended separation. The name honors the ...

Medtronic has announced that its planned spinoff diabetes business will be named MiniMed, reviving the original name of the company acquired by Medtronic in 2001. The separation is expected to ...

Insulin Pump Risks and Benefits A Clinical Appraisal of Pump Safety Standards, Adverse Event Reporting, and Research Needs. A Joint Statement of the European Association for the Study of Diabetes ...

A recent Medtronic MiniMed Paradigm and 530G pump recall included 444,374 units in the US and 293,000 patients elsewhere. [9] ...

Medtronic, which announced last month it will spin off its $2.8 billion diabetes unit as a standalone public company, has chosen a new name for the business once it separates.

The t:slim X2 insulin pump is powered by Control-IQ+ technology, the latest generation of Tandem's advanced hybrid closed-loop algorithm, which adjusts insulin every 5 minutes based on predicted ...

The non-profit drugmaker plans to launch biosimilars of Sanofi’s Lantus (insulin glargine), Novo Nordisk’s Novolog (insulin aspart) and Eli Lilly’s Humalog (insulin lispro) by 2024.

The pancreas plays a role in diabetes because it produces insulin and helps regulate blood sugar levels. We look into the links between diabetes and the pancreas.